These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20686147)

  • 21. Aripiprazole and depression in schizoaffective disorder.
    Errico JR; Yates WR
    Am J Psychiatry; 2005 Mar; 162(3):626-7. PubMed ID: 15741489
    [No Abstract]   [Full Text] [Related]  

  • 22. Hereditary spastic paraplegia and psychosis: connected by the corpus callosum?
    Osmolak AM; Wallenberg RB; Caplan JP
    Psychosomatics; 2012; 53(1):81-4. PubMed ID: 22118709
    [No Abstract]   [Full Text] [Related]  

  • 23. Rapid response to antipsychotic treatment on psychotic prodrome: implications from a case series.
    Liu CC; Sheu YH; Wu SY; Lai MC; Hwu HG
    Psychiatry Clin Neurosci; 2010 Apr; 64(2):202-6. PubMed ID: 20447014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aripiprazole monotherapy in the treatment of vascular parkinsonism.
    Ishitobi M; Kosaka H; Takahashi T; Oonuma M; Murata T; Wada Y
    Psychiatry Clin Neurosci; 2011 Oct; 65(6):607. PubMed ID: 22003998
    [No Abstract]   [Full Text] [Related]  

  • 25. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
    Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Jing Y; Kim E; You M; Pikalov A; Tran QV
    J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.
    Friedman JH; Berman RM; Goetz CG; Factor SA; Ondo WG; Wojcieszek J; Carson WH; Marcus RN
    Mov Disord; 2006 Dec; 21(12):2078-81. PubMed ID: 17013906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aripiprazole for the management of olanzapine-induced weight gain.
    Englisch S; Weinbrenner A; Inta D; Zink M
    Pharmacopsychiatry; 2009 Jul; 42(4):166-7. PubMed ID: 19585397
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
    McQuade RD; Stock E; Marcus R; Jody D; Gharbia NA; Vanveggel S; Archibald D; Carson WH
    J Clin Psychiatry; 2004; 65 Suppl 18():47-56. PubMed ID: 15600384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Augmentation of clozapine treatment with aripiprazole.
    Lim S; Bowers MB
    J Clin Psychiatry; 2007 May; 68(5):798-9. PubMed ID: 17503993
    [No Abstract]   [Full Text] [Related]  

  • 31. Worsening schizoaffective disorder with aripiprazole.
    Reeves RR; Mack JE
    Am J Psychiatry; 2004 Jul; 161(7):1308. PubMed ID: 15229073
    [No Abstract]   [Full Text] [Related]  

  • 32. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manic episode during treatment with aripiprazole.
    Padala PR; Wengel SP; Petty F
    Am J Psychiatry; 2007 Jan; 164(1):172-3. PubMed ID: 17202565
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of aripiprazole for psychosis and agitation in dementia.
    Laks J; Miotto R; Marinho V; Engelhardt E
    Int Psychogeriatr; 2006 Jun; 18(2):335-40. PubMed ID: 16255839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of findings in aripiprazole for treatment of psychoses in Alzheimer dementia.
    Tsai AC
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):613; author reply 614. PubMed ID: 18591582
    [No Abstract]   [Full Text] [Related]  

  • 36. Aripiprazole-induced improvement in tardive dyskinesia.
    Duggal HS
    Can J Psychiatry; 2003 Dec; 48(11):771-2. PubMed ID: 14733461
    [No Abstract]   [Full Text] [Related]  

  • 37. Aripiprazole treatment in an adolescent patient with chronic motor tic disorder and treatment-resistant obsessive-compulsive disorder.
    Lai CH
    Int J Neuropsychopharmacol; 2009 Oct; 12(9):1291-3. PubMed ID: 19706223
    [No Abstract]   [Full Text] [Related]  

  • 38. Aripiprazole treatment of psychosis in a child with posterior fossa retrocerebellar arachnoid cyst.
    Kalapatapu RK
    J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):321-5. PubMed ID: 19519272
    [No Abstract]   [Full Text] [Related]  

  • 39. Extensive weight loss in a patient with schizophrenia after switching from olanzapine to aripiprazole. A case report.
    Luebbe G; Kropp S; Harms E; Ziegenbein M
    Pharmacopsychiatry; 2006 Mar; 39(2):76. PubMed ID: 16555168
    [No Abstract]   [Full Text] [Related]  

  • 40. Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients.
    Chen CH; Huang MC; Lu ML
    J Clin Psychopharmacol; 2007 Oct; 27(5):516-7. PubMed ID: 17873689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.